Cited by 103Cardiac Imaging and DiagnosticsCardiovascular Health and Disease PreventionCerebrovascular and Carotid Artery Diseases

Short-term progression of multiterritorial subclinical atherosclerosis

Open access
López-Melgar, Beatriz, Fernández-Friera, Leticia, Oliva, Belén, García-Ruiz, José Manuel, Sánchez-Cabo, Fátima, Bueno, Héctor, Mendiguren, José María, Lara-Pezzi, Enrique +5 more·2020·Journal of the American College of Cardiology

Abstract

Atherosclerosis progression predicts cardiovascular events; however, progression of multiterritorial subclinical atherosclerosis is incompletely understood. This study sought to study short-term progression of atherosclerosis using different noninvasive imaging techniques and their relationship with cardiovascular risk. The study included 3,514 PESA (Progression of Early Subclinical Atherosclerosis) study participants (45.7 ± 4.2 years of age; 63% men). Participants underwent 2-dimensional vascular ultrasound (2DVUS) of abdominal aorta, carotid, iliac, and femoral territories to determine a plaque number score; 3DVUS to quantify carotid and femoral plaque volume; and coronary artery calcium score (CACS) at baseline and 2.8 years later. The authors calculated the rate of new disease incidence and changes in disease extent. Logistic regression models were used to evaluate associations of progression rates with baseline cardiovascular risk factors and estimated 10-year risk. Imaging detected short-term (3-year) atherosclerosis progression in 41.5% of participants (26.4% by 2DVUS, 21.3% by 3DVUS, and 11.5% by CACS), particularly in peripheral territories examined by vascular ultrasound. New atherosclerosis onset accounted for approximately one-third of total progression, also more frequently by 2DVUS and 3DVUS (29.1% and 16.6%, respectively), than by CACS (2.9%). Participants with baseline disease by all 3 modalities (n = 432) also showed significant atherosclerosis progression (median: 1 plaque [interquartile range (IQR): −1 to 3 plaques] by 2DVUS; 7.6 mm3 [IQR: −32.2 to 57.6 mm3] by 3DVUS; and 21.6 Agatston units [IQR: 4.8 to 62.6 Agatston units] by CACS). Age, sex, dyslipidemia, hypertension, smoking, and family history of premature cardiovascular disease contributed to progression, with dyslipidemia the strongest modifiable risk factor. Although disease progression correlated with cardiovascular risk, progression was detected in 36.5% of participants categorized as low risk. With this multimodal and multiterritorial approach, the authors detected short-term progression of early subclinical atherosclerosis in a substantial proportion (41.5%) of apparently healthy middle-aged men and women, more frequently by peripheral 2D/3DVUS than by CACS. Disease progression, as defined in this study, correlated with almost all cardiovascular risk factors and estimated risk. (Progression of Early Subclinical Atherosclerosis [PESA]; NCT01410318)

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2020.02.026

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Dyslipidemia leads to cardiovascular events by atherosclerotic plaque development and progression.

    “Dyslipidemia leads to CV events by atherosclerotic plaque development and progression (5,6).”

    From Triglycerides and residual atherosclerotic risk (2021) · cites this paper as [6]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 37 · Cited by 103

Authors
López-Melgar, B., Fernández-Friera, L., Oliva, B., García-Ruiz, J. M., Sánchez-Cabo, F., Bueno, H., Mendiguren, J. M., Lara-Pezzi, E., Andrés, V., Ibáñez, B., Fernández-Ortiz, A., Sanz, J., & Fuster, V.
Affiliations
Spanish National Centre for Cardiovascular Research (ES)
Corresponding author
Sanz, Javier
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2020-04
Volume
75
Issue
14
Pages
1617-1627
ISSN
0735-1097 (ISSN-L)
OpenAlex
W3014332665
Cited by
103
References
37
Citations by year
2026: 12 · 2025: 17 · 2024: 16 · 2023: 22 · 2022: 11 · 2021: 16 · 2020: 9
FWCI
7.09
Type
journal article
Language
en
Open access
Locations
  • Journal of the American College of Cardiology (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-nd)
Funders
  • Instituto de Salud Carlos III
  • Ministerio de Ciencia e Innovación
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cerebrovascular and Carotid Artery Diseases
Keywords
subclinical atherosclerosis, atherosclerosis progression, coronary artery calcium score, carotid plaque volume, peripheral arterial disease, vascular ultrasound, cardiovascular risk factors, dyslipidemia, 10-year cardiovascular risk, middle-aged men
MeSH terms
Heart Disease Risk Factors, Arteries, Cardiovascular Diseases, Coronary Artery Disease, Female, Humans, Male, Middle Aged, Research Design, Time Factors, Incidence, Disease Progression, Ultrasonography, Doppler, Early Diagnosis, Dyslipidemias, Atherosclerosis, Plaque, Atherosclerotic, Peripheral Arterial Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review